In an analogy to "the cleaners" who are called on to "fix the mess" done by others, cardiologists are called on to treat drug-induced TdP. Surprisingly, contemporary textbooks dedicate only a few lines to the treatment of TdP (6) . Recommendations include the following: 1) discontinuation of the culprit drug;
2) administration of intravenous magnesium; and/or 3) intravenous isoproterenol or temporary cardiac pacing. Because TdP may present as an arrhythmic storm, it is timely to review the rationale behind these recommendations.
Discontinuation of the culprit drug, although an obvious first step, is essentially a "virtual step" at This led to a prospective study of 12 patients who were treated with magnesium sulfate (injected as a slow bolus of 2 g magnesium over 1 to 2 min, "often followed" by a continuous infusion of 3 to 20 mg/ min): 9 patients responded immediately, and the remaining 3 responded to a second magnesium bolus (9) . As noted in the original report (9) , magnesium suppresses TdP without shortening the QT interval, presumably by suppressing the EADs that trigger TdP (10) . EAD suppression by magnesium has been attributed to its calcium channel-blocking effects (11) but may also be mediated by a reduction of the late they have no relationships relevant to the contents of this paper to disclose. E-mail: samiviskin@gmail.com.
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